Genetic variations in DNA synthesis gene Rpa3 have been associated with susceptibility to carcinomas [51], whereas increased cancer expression of Rpa2 is associated with adverse outcome in colon cancer [52]. This evidence concerns the gene RPA3 and carcinoma.